Fed. Circ. Backs UK Pharma Firm's IP Win Against CBD Giant
The Federal Circuit upheld on Monday a win secured by British pharmaceutical firm GW Pharmaceuticals in a patent suit brought by cannabis giant Canopy Growth, which accused the former of pinching...To view the full article, register now.
Already a subscriber? Click here to view full article